Screening for Fetal Chromosomal Abnormalities

Publication Date: October 1, 2020
Last Updated: March 14, 2022

Recommendations

Prenatal genetic screening (serum screening with or without nuchal translucency [NT] ultrasound or cell-free DNA screening) and diagnostic testing (chorionic villus sampling [CVS] or amniocentesis) options should be discussed and offered to all pregnant women regardless of maternal age or risk of chromosomal abnormality. After review and discussion, every patient has the right to pursue or decline prenatal genetic screening and diagnostic testing. (A)
328407

Overview

Title

Screening for Fetal Chromosomal Abnormalities

Authoring Organization

American College of Obstetricians and Gynecologists